Annual Current Liabilities
$72.79 M
+$8.29 M+12.85%
31 December 2023
Summary:
Adaptimmune Therapeutics annual total current liabilities is currently $72.79 million, with the most recent change of +$8.29 million (+12.85%) on 31 December 2023. During the last 3 years, it has risen by +$33.72 million (+86.29%). ADAP annual current liabilities is now -2.05% below its all-time high of $74.31 million, reached on 31 December 2017.ADAP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$63.46 M
-$18.62 M-22.68%
30 September 2024
Summary:
Adaptimmune Therapeutics quarterly total current liabilities is currently $63.46 million, with the most recent change of -$18.62 million (-22.68%) on 30 September 2024. Over the past year, it has dropped by -$11.69 million (-15.56%). ADAP quarterly current liabilities is now -22.68% below its all-time high of $82.07 million, reached on 30 June 2024.ADAP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.8% | -15.6% |
| 3 y3 years | +86.3% | +54.3% |
| 5 y5 years | +197.9% | +69.7% |
ADAP Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +86.3% | -22.7% | +54.3% |
| 5 y | 5 years | at high | +197.9% | -22.7% | +112.8% |
| alltime | all time | -2.0% | +1735.2% | -22.7% | +219.9% |
Adaptimmune Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $63.46 M(-22.7%) |
| June 2024 | - | $82.07 M(+23.6%) |
| Mar 2024 | - | $66.41 M(-8.8%) |
| Dec 2023 | $72.79 M(+12.8%) | $72.79 M(-3.1%) |
| Sept 2023 | - | $75.15 M(-1.3%) |
| June 2023 | - | $76.13 M(+19.6%) |
| Mar 2023 | - | $63.63 M(-1.3%) |
| Dec 2022 | $64.50 M(+3.1%) | $64.50 M(-2.4%) |
| Sept 2022 | - | $66.08 M(-10.3%) |
| June 2022 | - | $73.63 M(+11.3%) |
| Mar 2022 | - | $66.15 M(+5.8%) |
| Dec 2021 | $62.54 M(+60.1%) | $62.54 M(+52.0%) |
| Sept 2021 | - | $41.14 M(-0.7%) |
| June 2021 | - | $41.42 M(+32.3%) |
| Mar 2021 | - | $31.31 M(-19.9%) |
| Dec 2020 | $39.07 M(+13.8%) | $39.07 M(+12.0%) |
| Sept 2020 | - | $34.90 M(-9.5%) |
| June 2020 | - | $38.56 M(+29.3%) |
| Mar 2020 | - | $29.82 M(-13.2%) |
| Dec 2019 | $34.34 M | $34.34 M(-8.2%) |
| Sept 2019 | - | $37.40 M(+32.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $28.29 M(+20.7%) |
| Mar 2019 | - | $23.43 M(-4.1%) |
| Dec 2018 | $24.44 M(-67.1%) | $24.44 M(-17.3%) |
| Sept 2018 | - | $29.57 M(-30.1%) |
| June 2018 | - | $42.31 M(-18.5%) |
| Mar 2018 | - | $51.92 M(-30.1%) |
| Dec 2017 | $74.31 M(+84.5%) | $74.31 M(+8.4%) |
| Sept 2017 | - | $68.57 M(+126.7%) |
| June 2017 | - | $30.25 M(-5.2%) |
| Mar 2017 | - | $31.91 M(-20.8%) |
| Dec 2016 | $40.27 M(+44.4%) | $40.27 M(+77.7%) |
| Sept 2016 | - | $22.66 M(+12.5%) |
| June 2016 | - | $20.14 M(+1.5%) |
| Mar 2016 | - | $19.84 M(-40.2%) |
| Dec 2015 | $27.89 M(+4.2%) | - |
| Sept 2015 | - | $33.18 M(-27.6%) |
| June 2015 | $26.77 M(-49.6%) | - |
| Dec 2014 | - | $45.85 M(-13.7%) |
| June 2014 | $53.11 M(+1239.0%) | $53.11 M |
| June 2013 | $3.97 M(-3.0%) | - |
| June 2012 | $4.09 M | - |
FAQ
- What is Adaptimmune Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual current liabilities year-on-year change?
- What is Adaptimmune Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly current liabilities year-on-year change?
What is Adaptimmune Therapeutics annual total current liabilities?
The current annual current liabilities of ADAP is $72.79 M
What is the all time high annual current liabilities for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual total current liabilities is $74.31 M
What is Adaptimmune Therapeutics annual current liabilities year-on-year change?
Over the past year, ADAP annual total current liabilities has changed by +$8.29 M (+12.85%)
What is Adaptimmune Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ADAP is $63.46 M
What is the all time high quarterly current liabilities for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly total current liabilities is $82.07 M
What is Adaptimmune Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ADAP quarterly total current liabilities has changed by -$11.69 M (-15.56%)